MANNKIND CORP Unrealized Gain (Loss) on Derivatives
MANNKIND CORP (MNKD) reported Unrealized Gain (Loss) on Derivatives of -$1.24 million for the 283-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2015-03-02
- MANNKIND CORP unrealized gain (loss) on derivatives for the quarter ending 2012-12-31 was -$13.25M.
- MANNKIND CORP unrealized gain (loss) on derivatives for the quarter ending 2012-09-30 was $0.00.
- MANNKIND CORP unrealized gain (loss) on derivatives for the quarter ending 2012-06-30 was $10.31M.
- MANNKIND CORP unrealized gain (loss) on derivatives for the quarter ending 2012-03-31 was $1.71M.
- MANNKIND CORP unrealized gain (loss) on derivatives for fiscal 2012 was -$1.24M.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 6 month as first filed | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 9 month as first filed | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 253 month | Unrealized Gain (Loss) on Derivatives 256 month | Unrealized Gain (Loss) on Derivatives 259 month | Unrealized Gain (Loss) on Derivatives 263 month | Unrealized Gain (Loss) on Derivatives 265 month | Unrealized Gain (Loss) on Derivatives 268 month | Unrealized Gain (Loss) on Derivatives 271 month | Unrealized Gain (Loss) on Derivatives 275 month | Unrealized Gain (Loss) on Derivatives 277 month | Unrealized Gain (Loss) on Derivatives 280 month | Unrealized Gain (Loss) on Derivatives 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | -$1.24M 10-Q · filed 2014-11-10 | ||||||||||||||||
| 2014-06-30 | -$1.24M 10-Q · filed 2014-08-11 | ||||||||||||||||
| 2014-03-31 | -$1.24M 10-Q · filed 2014-05-12 | ||||||||||||||||
| 2013-12-31 | -$1.24M 10-K · filed 2014-03-03 | ||||||||||||||||
| 2013-09-30 | -$1.24M 10-Q · filed 2013-11-12 | ||||||||||||||||
| 2013-06-30 | -$1.24M 10-Q · filed 2013-08-09 | ||||||||||||||||
| 2013-03-31 | -$1.24M 10-Q · filed 2013-05-10 | ||||||||||||||||
| 2012-12-31 | -$13.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$13.25M derived: sum of 2 quarters · filed 2015-03-02 | -$2.94M derived: sum of 3 quarters · filed 2015-03-02 | -$1.24M 10-K · filed 2015-03-02 | -$1.24M 10-K · filed 2013-03-18 | ||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $10.31M derived: sum of 2 quarters · filed 2013-11-12 | $12.01M 10-Q · filed 2013-11-12 | -$12.01M 10-Q · filed 2012-11-09 | -$12.01M 10-Q · filed 2012-11-09 | ||||||||||||
| 2012-06-30 | $10.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $12.01M 10-Q · filed 2013-08-09 | -$12.01M 10-Q · filed 2012-08-09 | -$12.01M 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | $1.71M 10-Q · filed 2013-05-10 | $1.71M 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |